03/22/2027
London,UK
Greetings from Brain disorder2026
Scientific progress in brain health depends on a deeper understanding of neurological conditions, advances in diagnosis, and the development of effective treatment approaches. Bringing these areas together is essential to improving clinical knowledge and shaping the future of neurological care.
It is our pleasure to welcome you to the 10th Annual Conference on Brain Disorders, Neurology and Therapeutics, taking place on March 22–23, 2027, in London, United Kingdom.
Theme: “Advancing Neurology Through Knowledge, Collaboration & Innovation.”
Brain Disorders 2027 aims to bring together neurologists, researchers, clinicians, healthcare professionals, and scientific experts to share research findings, discuss advances in neurological science, and explore new developments in therapeutic approaches. The conference offers an opportunity to learn from different perspectives, exchange professional experiences, and gain insights that can support further research and clinical practice.
We believe that meaningful scientific discussions and collaboration can open new directions for research and contribute to continued progress in understanding, diagnosing, and treating neurological conditions.
We warmly invite you to be part of this gathering, share your expertise, discover new perspectives, and contribute to the ongoing advancement of brain science, neurology, and therapeutics.
We look forward to welcoming you to London for Brain Disorders 2027.
With regards
Luna grace
Programme co coordinator
About Conference
Brain Disorders 2027 focuses on emerging research, evidence-based practices, and innovative approaches in brain disorders, neurology, and therapeutics. The conference encourages scientific discussion, fresh perspectives, and professional growth to support future developments in neurological science and patient care.
Conference at a Glance
Taking place on March 22–23, 2027, in London, United Kingdom, this two-day conference welcomes researchers, physicians, clinicians, academicians, healthcare professionals, and students to explore developments across brain disorders, clinical neurology, neuroscience, and therapeutics.
Dates: March 22–23, 2027
Location: London, United Kingdom
Duration: Two days
Timings: To be announced
Scientific Programme Highlights
Brain Disorders and Clinical Neurology: Current understanding, diagnosis, and management of neurological conditions.
Neuroscience and Neurodegenerative Diseases: Disease mechanisms, progression, and emerging research directions.
Neurological Diagnostics and Neuroimaging: Advances in neurological assessment, imaging, and early detection.
Therapeutic Precision Medicine: Emerging treatments, targeted therapies, and individualized care.
Clinical Trials and Translational Research: Moving scientific discoveries towards clinical application.
What Participants Can Take Away
Future Directions and Research Priorities
Continued progress in neurology requires focused research into early diagnosis, disease prevention, effective therapies, personalized treatment, and improved long-term patient outcomes. Greater collaboration between laboratory scientists, clinical researchers, healthcare professionals, and technology developers will be important in translating research findings into practical healthcare solutions.
Career and Professional Development
The fields covered by the conference offer diverse career pathways in:
Conference Schedule
The two-day programme is intended to support scientific learning, research exchange, and professional interaction. Session timings, presentation schedules, and programme details will be announced by the organizing committee.
1. Brain Disorders
Brain disorders touch millions of families, changing how a person thinks, moves, feels, and connects with loved ones. Behind every diagnosis is someone who wants to keep their independence and dignity. This session brings clinicians, researchers, and caregivers together to share what is known and what still needs answers. By attending, you will leave with a clearer picture of recent advances in Neuroscience and new referral and research contacts across disciplines.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
2. Neurodegeneration
Alzheimer’s, Parkinson’s, ALS, and Huntington’s slowly take away memory, movement, and speech, and families feel the loss alongside the patient. As populations age, this challenge grows every year. This session explores why brain cells fail and how we might slow or stop the process. By attending, you will hear the latest trial and biomarker results related to Dementia and find collaborators in a field where progress depends on shared effort.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
3. Stroke
Stroke strikes without warning, and every minute of delay costs the brain millions of cells. One event can change a person’s speech, movement, and role in the family. This session follows the full journey from the first symptom to recovery at home. By attending, you will pick up practical protocols for faster response and recovery pathways you can use in your hospital or community, supporting improved Therapeutics and patient care.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
4. Neuropsychiatry
The mind and brain are not separate, and many people with neurological illness also live with depression, anxiety, or personality changes. These patients are often caught between two specialties and misunderstood by both. This session bridges that gap and treats emotional symptoms as real medical conditions. By attending, you will gain practical skills to recognize these symptoms and build a network across both fields of Neurology and mental health.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
5. Autism and ADHD
Children and adults with autism and ADHD think differently, and with the right support they can thrive at school, at work, and in relationships. Delayed diagnosis and limited understanding still hold many of them back. This session puts families, teachers, and neuro divergent people at the center, with equal focus on strengths and challenges. By attending, you will take away current screening tools, proven support methods, and ways to work with families and schools to improve Therapeutics and long-term support.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
6. Neuromuscular Disorders
Muscular dystrophy, myasthenia gravis, and spinal muscular atrophy can turn walking, swallowing, or breathing into daily struggles. Many begin in childhood and affect the whole family. This session celebrates recent breakthroughs, especially gene-based therapies, while addressing the long road of everyday care. By attending, you will learn about new treatments and care models and connect with patient support groups advancing Neuroscience research.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
7. Epilepsy
Epilepsy affects people of all ages, yet fear and myths still isolate those who live with it. Seizures can disrupt school, driving, work, and safety. This session focuses on seizure freedom while protecting dignity and normal life, with neurologists, surgeons, and people who have lived the journey. By attending, you will see new treatment options and gain ideas for reducing stigma in your own community.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
8. Clinical Neurology
In neurology, careful listening and examination still guide the most important decisions. Patients arrive with headaches, dizziness, tremors, or numbness, and the doctor must find the cause quickly. This session brings the real challenges of the clinic and ward to the table. By attending, you will sharpen your diagnostic thinking, learn from complex cases involving conditions such as Migraine, and take home updated guidance for daily practice.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
9. Pediatric Neurology
When a child has a neurological condition, parents face uncertainty about development, schooling, and the future. Early recognition can change a child’s entire path. This session focuses on babies, children, and teenagers, and places the child and family first. By attending, you will gain tools for early detection, learn about child-specific treatments, and find better ways to support families through long journeys in Neurology.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
10. Neuro immunology
Sometimes the body’s own defenses turn against the brain and nerves, as in multiple sclerosis and brain inflammation. Patients are often young, and symptoms can appear suddenly. This session explores how the immune and nervous systems interact and how that knowledge is changing treatment. By attending, you will learn about newer therapies, better testing, and ways to support patients over the long term through advances in Therapeutics.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
11. Neuro genetics
Many neurological conditions run in families, and a genetic result can bring both answers and anxiety. New testing now helps families end years of searching for a diagnosis. This session shows how genetics is moving from the lab to the bedside, including its emotional and ethical side. By attending, you will learn how to choose and explain genetic tests and meet others working on shared questions in Neuroscience.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
12. Neuroimaging
Brain scans let us see inside the living brain without surgery, turning hidden suffering into clear evidence. Each scan helps doctors decide how to treat and how to reassure patients and families. This session shows how new imaging is finding disease earlier and guiding treatment more precisely. By attending, you will see the latest techniques in action, including imaging approaches relevant to Dementia, and feel more confident using them in clinical decisions.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
13. Neuroplasticity
The brain can change and rewire itself throughout life, and that is the foundation of recovery. A stroke survivor relearning to walk or a child building new skills is plasticity at work. This session explores how therapy, practice, and technology can drive that change. By attending, you will discover proven ways to boost recovery and ideas to build into your rehabilitation programs using evidence-based Therapeutics.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
14. Neuro AI
Artificial intelligence is starting to read scans, predict seizures, and spot early signs of memory loss. It also raises honest questions about trust, fairness, and the role of the doctor. This session shows where AI truly helps patients and where human judgment must stay in charge. By attending, you will learn which tools are ready for practice, how to judge them wisely, and where to find partners for joint projects in Neuroscience.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
15. Neuropharmacology
Medicines are often the first line of help for people with neurological and mental health conditions, but side effects and trial and error can be hard on patients. This session looks at how drugs work in the nervous system and how to choose better ones for each person. It also previews the next wave of medicines in development. By attending, you will gain updates on new drugs and safer prescribing, and see where Therapeutics is heading.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
16. Stem Cell Therapy
Stem cells offer hope of replacing what damaged brains and spinal cords have lost, and many patients are eager for a cure. That hope must be matched with honesty about what science can and cannot yet deliver. This session separates promising research from unproven claims. By attending, you will learn which approaches are in real clinical trials and how to guide patients away from unsafe clinics while exploring advances in Neuroscience.
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
17. Neuro technology
Devices that read or influence brain activity are moving from science fiction into clinics, helping paralyzed people communicate and move again. These tools change lives, and they also raise new questions about privacy and access. This session brings together the engineers, doctors, and users shaping them. By attending, you will see live demonstrations, learn what is available today, and meet innovators looking for clinical partners in Neurology.
Tracks:
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
18. Drug Delivery
Even the best medicine fails if it cannot reach the brain, because a natural barrier blocks most drugs. Solving this could unlock treatments for conditions that are hard to treat today. This session explores clever ways to carry medicines safely into the brain, so patients get stronger effects with fewer side effects. By attending, you will learn about new delivery methods and how lab ideas become real Therapeutics
Tracks:
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
19. Case Reports
Every unusual case holds a lesson, and many medical advances began with one patient’s puzzling story. This session gives doctors, residents, and students a stage to share rare presentations, surprising diagnoses, and treatment lessons. Learning from each other’s experience makes everyone’s practice safer. By attending, you will gain practical clinical tips, get feedback from experienced peers, and have the chance to present and publish your own case in Neurology.
Related Conferences
Brain Disorders Conferences | Neurology Conferences | Neuroscience Conferences | Neurodegenerative Disorders Conferences | Epilepsy Conferences | Stroke Conferences | Neuropsychiatry Conferences | Neuro therapeutics Conferences | Neurological Disorders Conferences | Brain Science Conferences
20. Keynote Panels
The keynote panels bring leaders in neuroscience together to discuss where the field has been and where it is heading. These are open conversations on the questions that matter most to patients and society, with researchers, doctors, policymakers, and patient advocates on one stage. By attending, you will gain big-picture insight, draw inspiration from pioneers, and get the chance to put your own questions to the people shaping the future of Neuroscience.
Related Journals
Brain Disorders Journals | Neurology Journals | Neuroscience Journals | Neurodegenerative Disorders Journals | Dementia Journals | Epilepsy Journals | Stroke Journals | Neuro genetics Journals | Neuro immunology Journals | Clinical Neurology Journals | Neuroscience Research Journals
Global Market Overview
The global neurological disorder therapeutics market is witnessing considerable expansion, driven by advancements in medical research, treatment innovation, and the increasing prevalence of neurological conditions. The market was estimated at USD 98.12 billion in 2025 and is anticipated to increase from USD 105.44 billion in 2026 to USD 151.09 billion by 2031, representing a compound annual growth rate (CAGR) of 7.46% during 2026–2031. North America holds a leading position in the global marketplace, whereas the Asia-Pacific region is expected to demonstrate significant growth potential.
Neurology and brain disorders constitute a major area of healthcare research dedicated to understanding, diagnosing, and managing conditions affecting the central and peripheral nervous systems. Major areas of concern include Alzheimer's disease, Parkinson's disease, epilepsy, stroke, multiple sclerosis, brain tumors, and other neurological and neurodegenerative conditions.
Continuous progress in neurological research, combined with increasing demand for effective therapeutic interventions, is encouraging the development of advanced treatment modalities. Emerging approaches such as precision-based therapies, genetic medicine, neuroprotective interventions, and innovative neurological technologies are contributing to the advancement of patient care.
The growing need for early diagnosis, effective disease management, and improved therapeutic outcomes is further strengthening opportunities for scientific investigation, pharmaceutical development, and specialized neurological services.
Growth Drivers
• Increasing incidence of neurological conditions: The expanding elderly population and rising occurrence of age-associated neurological diseases, including dementia, Alzheimer's disease, and Parkinson's disease, are contributing to greater demand for neurological healthcare.
• Progress in neuroscience and clinical research: Enhanced understanding of neural mechanisms, brain functioning, disease progression, and molecular pathways is facilitating the identification of promising therapeutic targets.
• Emergence of innovative treatment approaches: Developments in biologics, targeted drug therapies, disease-modifying treatments, and neuroprotective interventions are broadening the scope of neurological treatment.
• Advancement of personalized healthcare: Genetic analysis, molecular diagnostics, and individualized treatment strategies are supporting the transition toward more precise and patient-oriented neurological care.
• Expansion of pharmaceutical research and clinical trials: Growing investments from biotechnology companies, pharmaceutical industries, and academic institutions are accelerating the discovery and evaluation of novel neurological therapies.
• Integration of artificial intelligence and diagnostic innovations: AI-assisted analysis, advanced neuroimaging, computational technologies, and digital biomarkers are improving diagnostic capabilities and facilitating the identification of neurological abnormalities.
• Increasing accessibility to specialized neurological care: Greater public awareness, improvements in healthcare infrastructure, and expansion of specialized treatment facilities are contributing to the development of neurological healthcare services.
Future Outlook (2026–2031)
The neurological therapeutics sector is anticipated to maintain a positive growth trajectory throughout the forecast period, with its global valuation projected to reach approximately USD 151.09 billion by 2031. Increasing disease prevalence, continuous pharmaceutical innovation, and expanding research activities are expected to remain major contributors to market development.